This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
3-5 November 2026
RAIAmsterdam, Netherlands

Bhavani Prasad Vinjamuri, Ph.D
Scientist II at Biogen
Speaker

Profile

Prasad is a Scientist in Technical Development at Biogen, based in Cambridge, Massachusetts, USA. His work centers on oligonucleotide drug product formulation and process development, with responsibilities spanning drug product lead for ASOs with new chemistries, siRNA, and AOC. Externally, he leads in-use studies sub-team for the European Pharma Oligonucleotide Consortium (EPOC). His scientific interests focus on the intersection of formulation science, sterile process development, and CMC regulatory strategy for antisense oligonucleotides and related modalities. Prasad brings over seven years of industry experience across sterile injectables, topical, and inhalation dosage forms. He received his Ph.D. in Pharmaceutics and Drug Delivery from The University of Mississippi and, M.S. in Pharmaceutical Sciences from Campbell University, NC, USA, and B.Pharm from Andhra University, India.

Agenda Sessions

  • Finding the Right Balance: How Formulation Aspects and Regulatory Expectations Affect Steam Sterilization of Antisense Oligonucleotide (ASO) Drug Products

    10:15